Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00214942 · ClinicalTrials.gov registry record · Phase 3
Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain
A Phase 3 study, sponsored by Cephalon.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00214942: Completed Phase 3 study, sponsored by Cephalon.
NCT00214942 is a Phase 3 study that has completed, run by Cephalon. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00214942, a Phase 3 study, has completed, sponsored by Cephalon.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain in Opioid-Tolerant Patients with Chronic Low Back Pain
Interventions
- DRUG ORAVESCENT Fentanyl Citrate
Trial Details
| Field | Value |
|---|---|
| Start Date | 2005-09 |
| Phase | Phase 3 |
What the finished NCT00214942 record still lists
NCT00214942 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which ORAVESCENT Fentanyl Citrate is the first listed.
NCT00214942 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00214942 about?
NCT00214942 is a clinical study titled "Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain". A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain in Opioid-Tolerant Patients with Chronic Low Back Pain
What is the current status of trial NCT00214942?
This trial is currently completed. It is a Phase 3 study. The study started on 2005-09.
What interventions are being tested in trial NCT00214942?
The interventions under investigation include: ORAVESCENT Fentanyl Citrate (DRUG).
Who is sponsoring clinical trial NCT00214942?
This trial is sponsored by Cephalon, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia